Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / March / Red Eye Global Challenge
Anterior Segment Health Economics and Policy News

Red Eye, Global Challenge

Narrative review calls for clearer guidance on noninfectious conjunctival hyperemia

3/18/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Clinical Report: Red Eye, Global Challenge

Overview

A narrative review highlights the increasing global burden of noninfectious conjunctival hyperemia, driven by lifestyle and environmental factors. It emphasizes the need for clearer diagnostic pathways and safer long-term treatment options.

Background

Conjunctival hyperemia is one of the most common ophthalmic presentations, with a prevalence influenced by factors such as digital eye strain, contact lens wear, and ocular allergies. The rising incidence of dry eye disease and ocular allergies necessitates improved management strategies. Current treatment practices are often suboptimal, highlighting the need for formal guidelines and patient education.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Conjunctival hyperemia is increasingly common due to lifestyle and environmental factors.
  • Dry eye disease (DED) and ocular allergy are leading causes of chronic redness, with DED prevalence estimates ranging from 5–50%.
  • Low-dose brimonidine 0.025% shows significant redness reduction without tachyphylaxis over 29 days.
  • There is a concerning trend of steroid self-medication in some regions, delaying proper management.
  • Patients often seek treatment for cosmetic reasons, influenced by social media and video conferencing.
  • There is a lack of dedicated management guidelines for noninfectious conjunctival hyperemia.

Clinical Implications

Clinicians must balance the medical necessity of treating conjunctival hyperemia with patients' aesthetic expectations. Improved diagnostic pathways and management guidelines are essential to address both clinical and cosmetic concerns effectively.

Conclusion

The review underscores the urgent need for consensus recommendations and improved patient education regarding noninfectious conjunctival hyperemia. As demand for effective treatment grows, so does the responsibility of clinicians to provide safe and effective care.

References

  1. Contact Lens Spectrum, Is This the New Norm?, 2014 -- Point-of-Care Testing for Red Eye
  2. Contact Lens Spectrum, Reader's Forum, 2006 -- A Case of Red Eye Induced by Cosmetic Skin Treatment
  3. Contact Lens Spectrum, Practical Red Eye Problem-Solving, 2015 -- A look at potential causes of red eye
  4. Red Eye - Ophthalmology - Merck Manual Professional Edition -- Symptoms of Ophthalmologic Disorders
  5. TFOS DEWS III: Executive Summary - ScienceDirect -- Dry Eye Disease
  6. Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI Guidelines—2024–2025 Revision
  7. Contact Lens Spectrum — DRY EYE DX AND TX
  8. Red Eye - Ophthalmology - Merck Manual Professional Edition
  9. TFOS DEWS III: Executive Summary - ScienceDirect
  10. Allergic Rhinitis and Its Impact on Asthma (ARIA)‐EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments
  11. Frontiers | Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: